Upstream Bio, Inc. Financial Overview
Upstream Bio, Inc.'s market cap is currently $1.50B. The company's EPS TTM is $-0.63; its P/E ratio is -12.15; Upstream Bio, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
